758 (Venlafaxine Hydrochloride Extended Release 150 mg)
Pill with imprint 758 is Pink & White, Elliptical/Oval and has been identified as Venlafaxine Hydrochloride Extended Release 150 mg. It is supplied by Sun Pharmaceutical Industries Ltd.
Venlafaxine is used in the treatment of autism; anxiety; depression; generalized anxiety disorder; major depressive disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 758


Venlafaxine Hydrochloride Extended Release
- Imprint
- 758
- Strength
- 150 mg
- Color
- Pink & White
- Size
- 16.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Ltd
- National Drug Code (NDC)
- 41616-0758 (Discontinued)
- Inactive Ingredients
-
hypromellose 2208 (4000 mPa.s),
povidone k30,
lactose monohydrate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
magnesium silicate,
magnesium stearate,
microcrystalline cellulose,
crospovidone,
silicon dioxide,
sodium lauryl sulfate,
FD&C Red No. 40,
mannitol,
dibutyl sebacate,
triethyl citrate,
polysorbate 20,
polyethylene glycol 3350,
polysorbate 80,
polyvinyl alcohol
Note: Inactive ingredients may vary.
Related images for "758"
More about venlafaxine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2,584)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: serotonin-norepinephrine reuptake inhibitors
Patient resources
- Drug Information
- Venlafaxine (Advanced Reading)
- Venlafaxine Extended-Release Tablets
- Venlafaxine Tablets
- Venlafaxine Extended-Release Capsules
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.